-
1
-
-
1642565876
-
Tumor hypoxia and malignant progression
-
Vaupel P, Mayer A, Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol. 2004;381:335-354
-
(2004)
Methods Enzymol
, vol.381
, pp. 335-354
-
-
Vaupel, P.1
Mayer, A.2
Hockel, M.3
-
2
-
-
0036359548
-
HypoxiaVa key regulatory factor in tumour growth
-
Harris AL. HypoxiaVa key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38-47
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 38-47
-
-
Harris, A.L.1
-
4
-
-
0034083413
-
Oxygenation of advanced head and neck cancer: Prognostic marker for the response to primary radiochemotherapy
-
Vanselow B, Eble MJ, Rudat V, et al. Oxygenation of advanced head and neck cancer: Prognostic marker for the response to primary radiochemotherapy. Otolaryngol Head Neck Surg. 2000;122:856-862
-
(2000)
Otolaryngol Head Neck Surg
, vol.122
, pp. 856-862
-
-
Vanselow, B.1
Eble, M.J.2
Rudat, V.3
-
5
-
-
14844292125
-
Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer
-
Prosnitz RG, Yao B, Farrell CL, et al. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:1087-1095
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.61
, pp. 1087-1095
-
-
Prosnitz, R.G.1
Yao, B.2
Farrell, C.L.3
-
6
-
-
33750108975
-
Hypoxia in head and neck cancer
-
Isa AY, Ward TH, West CM, et al. Hypoxia in head and neck cancer. Br J Radiol. 2006;79:791-798
-
(2006)
Br J Radiol
, vol.79
, pp. 791-798
-
-
Isa, A.Y.1
Ward, T.H.2
West, C.M.3
-
7
-
-
34547121206
-
Hypoxia in cancer: Significance and impact on clinical outcome
-
Vaupel P, Mayer A. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225-239
-
(2007)
Cancer Metastasis Rev
, vol.26
, pp. 225-239
-
-
Vaupel, P.1
Mayer, A.2
-
8
-
-
0033048571
-
Tissue oxygen distribution in head and neck cancer patients
-
Adam MF, Gabalski EC, Bloch DA, et al. Tissue oxygen distribution in head and neck cancer patients. Head Neck. 1999;21:146-153
-
(1999)
Head Neck
, vol.21
, pp. 146-153
-
-
Adam, M.F.1
Gabalski, E.C.2
Bloch, D.A.3
-
10
-
-
0029955072
-
Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
-
Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1996;41:31-39
-
(1996)
Radiother Oncol
, vol.41
, pp. 31-39
-
-
Nordsmark, M.1
Overgaard, M.2
Overgaard, J.3
-
11
-
-
0030742027
-
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
-
Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285-289
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.38
, pp. 285-289
-
-
Brizel, D.M.1
Sibley, G.S.2
Prosnitz, L.R.3
-
12
-
-
0344936018
-
Oxygenation of squamous cell carcinoma of the head and neck: Comparison of primary tumors, neck node metastases, and normal tissue
-
Becker A, Hansgen G, Bloching M, et al. Oxygenation of squamous cell carcinoma of the head and neck: Comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys. 1998;42:35-41
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.42
, pp. 35-41
-
-
Becker, A.1
Hansgen, G.2
Bloching, M.3
-
13
-
-
0037963317
-
Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-And-neck cancer patients
-
Le QT, Kovacs MS, Dorie MJ, et al. Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-And-neck cancer patients. Int J Radiat Oncol Biol Phys. 2003;56:375-383
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.56
, pp. 375-383
-
-
Le, Q.T.1
Kovacs, M.S.2
Dorie, M.J.3
-
14
-
-
33748185692
-
Imaging hypoxia after oxygenation-modification: Comparing [18f]fmiso autoradiography with pimonidazole immunohistochemistry in human xenograft tumors
-
Troost EG, Laverman P, Kaanders JH, et al. Imaging hypoxia after oxygenation-modification: Comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors. Radiother Oncol. 2006;80:157-164
-
(2006)
Radiother Oncol
, vol.80
, pp. 157-164
-
-
Troost, E.G.1
Laverman, P.2
Kaanders, J.H.3
-
15
-
-
34547984111
-
PO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: Validated methods for the evaluation of therapyrelevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?
-
Gagel B, Piroth M, Pinkawa M, et al. PO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: Validated methods for the evaluation of therapyrelevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? BMC Cancer. 2007;7:113
-
(2007)
BMC Cancer
, vol.7
, pp. 113
-
-
Gagel, B.1
Piroth, M.2
Pinkawa, M.3
-
16
-
-
34548511596
-
Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer
-
Grosu AL, Souvatzoglou M, Roper B, et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69:541-551
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
, pp. 541-551
-
-
Grosu, A.L.1
Souvatzoglou, M.2
Roper, B.3
-
17
-
-
33749344131
-
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer
-
Rajendran JG, Schwartz DL, O'Sullivan J, et al. Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res. 2006;12:5435-5441
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5435-5441
-
-
Rajendran, J.G.1
Schwartz, D.L.2
O'Sullivan, J.3
-
18
-
-
33646454133
-
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of trans-Tasman radiation oncology group study 98.02
-
Rischin D, Hicks RJ, Fisher R, et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of trans-Tasman radiation oncology group study 98.02. J Clin Oncol. 2006;24:2098-2104
-
(2006)
J Clin Oncol
, vol.24
, pp. 2098-2104
-
-
Rischin, D.1
Hicks, R.J.2
Fisher, R.3
-
19
-
-
15844368087
-
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in nonYsmall cell lung cancer and head and neck cancer before radiotherapy
-
Eschmann SM, Paulsen F, Reimold M, et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in nonYsmall cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med. 2005;46:253-260
-
(2005)
J Nucl Med
, vol.46
, pp. 253-260
-
-
Eschmann, S.M.1
Paulsen, F.2
Reimold, M.3
-
20
-
-
33748045490
-
Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-And-neck cancer patients
-
Thorwarth D, Eschmann SM, Holzner F, et al. Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-And-neck cancer patients. Radiother Oncol. 2006;80:151-156
-
(2006)
Radiother Oncol
, vol.80
, pp. 151-156
-
-
Thorwarth, D.1
Eschmann, S.M.2
Holzner, F.3
-
21
-
-
34250334707
-
Hypoxia-imaging with (18)Fmisonidazole and PET: Changes of kinetics during radiotherapy of head-Andneck cancer
-
Eschmann SM, Paulsen F, Bedeshem C, et al. Hypoxia-imaging with (18)Fmisonidazole and PET: Changes of kinetics during radiotherapy of head-Andneck cancer. Radiother Oncol. 2007;83:406-410
-
(2007)
Radiother Oncol
, vol.83
, pp. 406-410
-
-
Eschmann, S.M.1
Paulsen, F.2
Bedeshem, C.3
-
22
-
-
84868360868
-
Exploratory prospective trial of hypoxiaspecific PET imaging during radiochemotherapy in patients with locally advanced head-And-neck cancer
-
Zips D, Zophel K, Abolmaali N, et al. Exploratory prospective trial of hypoxiaspecific PET imaging during radiochemotherapy in patients with locally advanced head-And-neck cancer. Radiother Oncol. 2012;105:21-28
-
(2012)
Radiother Oncol
, vol.105
, pp. 21-28
-
-
Zips, D.1
Zophel, K.2
Abolmaali, N.3
-
23
-
-
41949118216
-
Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era
-
Garcia C, Flamen P. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era. Curr Opin Oncol. 2008;20:275-279
-
(2008)
Curr Opin Oncol
, vol.20
, pp. 275-279
-
-
Garcia, C.1
Flamen, P.2
-
24
-
-
80052278041
-
Preclinical evaluation and validation of [18f]hx4 a promising hypoxia marker for pet imaging
-
Dubois LJ, Lieuwes NG, Janssen MH, et al. Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging. Proc Natl Acad Sci U S A. 2011;108:14620-14625
-
(2011)
Proc Natl Acad Sci U S A.
, vol.108
, pp. 14620-14625
-
-
Dubois, L.J.1
Lieuwes, N.G.2
Janssen, M.H.3
-
25
-
-
84865709437
-
1)(8)F-HX4 hypoxia imaging with PET/CT in head and neck cancer: A comparison with (1)(8)F-FMISO
-
Chen L, Zhang Z, Kolb HC, et al. (1)(8)F-HX4 hypoxia imaging with PET/CT in head and neck cancer: A comparison with (1)(8)F-FMISO. Nucl Med Commun. 2012;33:1096-1102
-
(2012)
Nucl Med Commun
, vol.33
, pp. 1096-1102
-
-
Chen, L.1
Zhang, Z.2
Kolb, H.C.3
-
26
-
-
57149111715
-
18F-EF5: A new PET tracer for imaging hypoxia in head and neck cancer
-
Komar G, Seppanen M, Eskola O, et al. 18F-EF5: A new PET tracer for imaging hypoxia in head and neck cancer. J Nucl Med. 2008;49:1944-1951
-
(2008)
J Nucl Med
, vol.49
, pp. 1944-1951
-
-
Komar, G.1
Seppanen, M.2
Eskola, O.3
-
27
-
-
0038207686
-
Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio
-
Lehtio K, Oikonen V, Nyman S, et al. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio. Eur J Nucl Med Mol Imaging. 2003;30:101-108
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
, pp. 101-108
-
-
Lehtio, K.1
Oikonen, V.2
Nyman, S.3
-
28
-
-
3042518844
-
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-And-neck cancer
-
Lehtio K, Eskola O, Viljanen T, et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-And-neck cancer. Int J Radiat Oncol Biol Phys. 2004;59:971-982
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 971-982
-
-
Lehtio, K.1
Eskola, O.2
Viljanen, T.3
-
29
-
-
0035869722
-
A novel approach to overcome hypoxic tumor resistance: Cu-ATSMYguided intensity-modulated radiation therapy
-
Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSMYguided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2001;49:1171-1182
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.49
, pp. 1171-1182
-
-
Chao, K.S.1
Bosch, W.R.2
Mutic, S.3
-
30
-
-
15944397653
-
Preparation of the hypoxia imaging pet tracer [18f]faza: Reaction parameters and automation
-
Reischl G, Ehrlichmann W, Bieg C, et al. Preparation of the hypoxia imaging PET tracer [18F]FAZA: Reaction parameters and automation. Appl Radiat Isot. 2005;62:897-901
-
(2005)
Appl Radiat Isot
, vol.62
, pp. 897-901
-
-
Reischl, G.1
Ehrlichmann, W.2
Bieg, C.3
-
31
-
-
0032923678
-
Fluoroazomycin arabinoside (FAZA): Syn thesis, 2H and 3H-labelling and preliminary biological evaluation of a novel 2-nitroimidazole marker of tissue hypoxia
-
Kumar P, Stypinski D, Xie H, et al. Fluoroazomycin arabinoside (FAZA): Synthesis, 2H and 3H-labelling and preliminary biological evaluation of a novel 2-nitroimidazole marker of tissue hypoxia. J Label Compounds Radiopharm. 1999;42:3-16
-
(1999)
J Label Compounds Radiopharm
, vol.42
, pp. 3-16
-
-
Kumar, P.1
Stypinski, D.2
Xie, H.3
-
32
-
-
58149287834
-
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage
-
Busk M, Horsman MR, Jakobsen S, et al. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. Eur J Nucl Med Mol Imaging. 2008;35:2294-2303
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, pp. 2294-2303
-
-
Busk, M.1
Horsman, M.R.2
Jakobsen, S.3
-
33
-
-
0038058799
-
18F] fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): A comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors
-
Sorger D, Patt M, Kumar P, et al. [18F]fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): A comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol. 2003;30:317-326
-
(2003)
Nucl Med Biol
, vol.30
, pp. 317-326
-
-
Sorger, D.1
Patt, M.2
Kumar, P.3
-
34
-
-
15044349250
-
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside
-
Piert M, Machulla HJ, Picchio M, et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J Nucl Med. 2005;46:106-113
-
(2005)
J Nucl Med
, vol.46
, pp. 106-113
-
-
Piert, M.1
Machulla, H.J.2
Picchio, M.3
-
35
-
-
34250326197
-
Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine
-
Beck R, Roper B, Carlsen JM, et al. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine. J Nucl Med. 2007;48:973-980
-
(2007)
J Nucl Med
, vol.48
, pp. 973-980
-
-
Beck, R.1
Roper, B.2
Carlsen, J.M.3
-
36
-
-
39749202442
-
Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: A comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy
-
Busk M, Horsman MR, Jakobsen S, et al. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: A comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy. Int J Radiat Oncol Biol Phys. 2008;70:1202-1212
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.70
, pp. 1202-1212
-
-
Busk, M.1
Horsman, M.R.2
Jakobsen, S.3
-
37
-
-
69949180403
-
Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?
-
Busk M, Horsman MR, Jakobsen S, et al. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol. 2009;92:429-436
-
(2009)
Radiother Oncol
, vol.92
, pp. 429-436
-
-
Busk, M.1
Horsman, M.R.2
Jakobsen, S.3
-
38
-
-
21844455567
-
Hypoxia in head and neck cancer: How much, how important?
-
Janssen HL, Haustermans KM, Balm AJ, et al. Hypoxia in head and neck cancer: How much, how important? Head Neck. 2005;27:622-638
-
(2005)
Head Neck
, vol.27
, pp. 622-638
-
-
Janssen, H.L.1
Haustermans, K.M.2
Balm, A.J.3
-
39
-
-
77956566350
-
Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET
-
Busk M, Munk OL, Jakobsen S, et al. Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET. Acta Oncol. 2010;49:922-933
-
(2010)
Acta Oncol
, vol.49
, pp. 922-933
-
-
Busk, M.1
Munk, O.L.2
Jakobsen, S.3
-
40
-
-
82055164095
-
Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [ (1)(8)F]-fluoro- Azomycinarabino-furanoside ([(1)(8)F]FAZA
-
717X-6-165
-
Maier FC, Kneilling M, Reischl G, et al. Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [(1)(8)F]-fluoro-Azomycinarabino-furanoside ([(1)(8)F]FAZA). Radiat Oncol. 2011;6:165, 717X-6-165
-
(2011)
Radiat Oncol
, vol.6
, pp. 165
-
-
Maier, F.C.1
Kneilling, M.2
Reischl, G.3
-
41
-
-
79960370596
-
Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: A preclinical study
-
Mortensen LS, Busk M, Nordsmark M, et al. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: A preclinical study. Radiother Oncol. 2011;99:418-423
-
(2011)
Radiother Oncol
, vol.99
, pp. 418-423
-
-
Mortensen, L.S.1
Busk, M.2
Nordsmark, M.3
-
42
-
-
84874108264
-
PET hypoxia imaging with FAZA: Reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice
-
Busk M, Mortensen LS, Nordsmark M, et al. PET hypoxia imaging with FAZA: Reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice. Eur J Nucl Med Mol Imaging. 2013;40:186-197
-
(2013)
Eur J Nucl Med Mol Imaging
, vol.40
, pp. 186-197
-
-
Busk, M.1
Mortensen, L.S.2
Nordsmark, M.3
-
43
-
-
34548485457
-
Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: A pilot study
-
Souvatzoglou M, Grosu AL, Roper B, et al. Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: A pilot study. Eur J Nucl Med Mol Imaging. 2007;34:1566-1575
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 1566-1575
-
-
Souvatzoglou, M.1
Grosu, A.L.2
Roper, B.3
-
44
-
-
70350532485
-
Initial results of hypoxia imaging using 1-Alpha-D: -(5-deoxy-5-[18F]- fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA
-
Postema EJ, McEwan AJ, Riauka TA, et al. Initial results of hypoxia imaging using 1-Alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2- nitroimidazole (18F-FAZA). Eur J Nucl Med Mol Imaging. 2009;36:1565-1573
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 1565-1573
-
-
Postema, E.J.1
McEwan, A.J.2
Riauka, T.A.3
-
45
-
-
77956589424
-
Evaluating repetitive 18Ffluoroazomycin-Arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer
-
Schuetz M, Schmid MP, Potter R, et al. Evaluating repetitive 18Ffluoroazomycin-Arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncol. 2010;49:941-947
-
(2010)
Acta Oncol
, vol.49
, pp. 941-947
-
-
Schuetz, M.1
Schmid, M.P.2
Potter, R.3
-
46
-
-
77957088726
-
Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors
-
Shi K, Souvatzoglou M, Astner ST, et al. Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors. J Nucl Med. 2010;51:1386-1394
-
(2010)
J Nucl Med
, vol.51
, pp. 1386-1394
-
-
Shi, K.1
Souvatzoglou, M.2
Astner, S.T.3
-
47
-
-
80455174743
-
Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques
-
Garcia-Parra R, Wood D, Shah RB, et al. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques. Eur J Nucl Med Mol Imaging. 2011;38:1816-1823
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 1816-1823
-
-
Garcia-Parra, R.1
Wood, D.2
Shah, R.B.3
-
48
-
-
84868367617
-
FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial
-
Mortensen LS, Johansen J, Kallehauge J, et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial. Radiother Oncol. 2012;105:14-20
-
(2012)
Radiother Oncol
, vol.105
, pp. 14-20
-
-
Mortensen, L.S.1
Johansen, J.2
Kallehauge, J.3
-
49
-
-
84881426634
-
PET imaging of tumor hypoxia using 18F-fluorazomycin arabinoside in stage III-IV nonYsmall cell lung cancer patients
-
Bollineni VR, Kerner GS, Pruim J, et al. PET imaging of tumor hypoxia using 18F-fluorazomycin arabinoside in stage III-IV nonYsmall cell lung cancer patients. J Nucl Med. 2013;54:1175-1180
-
(2013)
J Nucl Med
, vol.54
, pp. 1175-1180
-
-
Bollineni, V.R.1
Kerner, G.S.2
Pruim, J.3
-
50
-
-
22244488361
-
Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: A prospective, randomized trial
-
Mendenhall WM, Morris CG, Amdur RJ, et al. Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: A prospective, randomized trial. Cancer. 2005;104:332-337
-
(2005)
Cancer
, vol.104
, pp. 332-337
-
-
Mendenhall, W.M.1
Morris, C.G.2
Amdur, R.J.3
-
51
-
-
79951938429
-
Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma
-
Hoskin PJ, Rojas AM, Bentzen SM, et al. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma. J Clin Oncol. 2010;28: 4912-4918
-
(2010)
J Clin Oncol
, vol.28
, pp. 4912-4918
-
-
Hoskin, P.J.1
Rojas, A.M.2
Bentzen, S.M.3
-
52
-
-
80051795366
-
Outcome after ARCON for clinical stage T2-4 laryngeal cancer: Early results of a phase III randomized trial
-
Kaanders J, Terhaard C, Doornaert P, et al. Outcome after ARCON for clinical stage T2-4 laryngeal cancer: Early results of a phase III randomized trial. Radiother Oncol. 2010;96(suppl 1):S158
-
(2010)
Radiother Oncol
, vol.96
, Issue.SUPPL. 1
-
-
Kaanders, J.1
Terhaard, C.2
Doornaert, P.3
-
53
-
-
84864003904
-
Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: Results of a phase III randomized trial
-
Janssens GO, Rademakers SE, Terhaard CH, et al. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: Results of a phase III randomized trial. J Clin Oncol. 2012;30:1777-1783
-
(2012)
J Clin Oncol
, vol.30
, pp. 1777-1783
-
-
Janssens, G.O.1
Rademakers, S.E.2
Terhaard, C.H.3
-
54
-
-
77954600498
-
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): A phase III trial of the transtasman radiation oncology group
-
Rischin D, Peters LJ, O'Sullivan B, et al. Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): A phase III trial of the transtasman radiation oncology group. J Clin Oncol. 2010;28:2989-2995
-
(2010)
J Clin Oncol
, vol.28
, pp. 2989-2995
-
-
Rischin, D.1
Peters, L.J.2
O'Sullivan, B.3
-
55
-
-
34347259579
-
The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments
-
Hoogsteen IJ, Marres HA, van der Kogel AJ, et al. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol (R Coll Radiol). 2007;19:385-396
-
(2007)
Clin Oncol (R Coll Radiol
, vol.19
, pp. 385-396
-
-
Hoogsteen, I.J.1
Marres, H.A.2
Van Der Kogel, A.J.3
|